News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rivard Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 150,000 shares
@ $1.11, valued at
$166.5k
|
|
| 08/18/2023 |
4
| Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $1.1232, valued at
$28.1k
|
|
| 06/09/2023 |
4
| Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 12/08/2022 |
4
| Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $1.53, valued at
$15.3k
|
|
| 11/24/2021 |
4
| Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $6.03, valued at
$90.5k
|
|
| 10/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|